SPARK Biopharma, Inc.
PrivateLast Round
Private Equity
May 11, 2026
Est. Valuation
$141.75M
Total Funding Raised
$70.23M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
SPARK Biopharma, Inc. is a biotechnology company that develops small-molecule therapeutics using phenotypic discovery platforms for the treatment of oncology, chronic inflammation, and immune disorders.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
SPARK Biopharma, Inc. Comparables
Compare SPARK Biopharma, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Octant | 78% | |
| Dalriada Drug Discovery | 71% | |
| Oncodesign Services | 69% |
SPARK Biopharma, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Private Equity | May 11, 2026 | ||||
| Series C | Apr 4, 2022 | ||||
| Strategic | Nov 25, 2021 | ||||
| Series B | Aug 26, 2019 | ||||
| Series A | Jul 1, 2018 |
SPARK Biopharma, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Shinhan Venture Investment | Series C |
| KB Investment | Series C, Series B |
| KB Investment | Series C, Series B, Series A |
| SJG Partners | Private Equity |
| Timefolio Asset Management | Series C |
| Company K Partners | Series C, Series B |
| KTB Ventures | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 11, 2026
$23M round with participation from SJG Partners and Shinhan Capital.
- Apr 4, 2022
$20.25M round with participation from Dt& Investment and Kiwoom Investment.
SPARK Biopharma, Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about SPARK Biopharma, Inc.'s valuation, stock price, and market status.
Is SPARK Biopharma, Inc. a public or private company?
SPARK Biopharma, Inc. is a private company.
What is the current stock price of SPARK Biopharma, Inc.?
SPARK Biopharma, Inc. is a private company with no public stock price. No recent secondary market data is available.
How much is SPARK Biopharma, Inc. worth (valuation)?
SPARK Biopharma, Inc.'s valuation is estimated at $141.8M based on funding round data.
Can I buy SPARK Biopharma, Inc. stock?
SPARK Biopharma, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was SPARK Biopharma, Inc.'s last funding round?
SPARK Biopharma, Inc.'s most recent funding round was Series C on April 4, 2022.
Who are the main investors in SPARK Biopharma, Inc.?
Key investors in SPARK Biopharma, Inc. include KTB Ventures.
Will SPARK Biopharma, Inc. IPO soon?
No public IPO plans have been announced for SPARK Biopharma, Inc..
How can I track SPARK Biopharma, Inc. secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor SPARK Biopharma, Inc.'s secondary market activity and sign up for updates.